FNY Managed Accounts’s BioTelemetry, Inc. BEAT Stock Holding History

FNY Managed Accounts’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,000	Closed	-$29K	–	986
2017 Q4	$29K	Buy	+1,000	New	+$29K	0.03%	117
2015 Q4	–	Sell	-2,500	Closed	-$30.6K	–	498
2015 Q3	$30.6K	Buy	+2,500	New	+$31.9K	0.09%	177
2015 Q2	–	Sell	-25,100	Closed	-$222K	–	679
2015 Q1	$222K	Buy	25,100 +15,100	+151%	+$153K	0.18%	71
2014 Q4	$100K	Sell	10,000 -17,000	-63%	-$146K	0.12%	97
2014 Q3	$181K	Buy	+27,000	New	+$189K	0.54%	42

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FNY Managed Accounts's BEAT Position: Q1 2018 in Review

FNY Managed Accounts sold out of BioTelemetry, Inc. (BEAT) in Q1 2018, closing a stake of 1,000 shares — an estimated $29K sold.

FNY Managed Accounts first reported a position in BEAT in Q3 2014 and held it in 5 quarters. The position peaked at $222K in Q1 2015. 202 funds tracked by Wall St. Rank hold BEAT as of Q1 2018.

FNY Managed Accounts reported no remaining BioTelemetry, Inc. position as of Q1 2018 after selling out during the quarter.
FNY Managed Accounts sold 1,000 BioTelemetry, Inc. shares in Q1 2018, an estimated $29K.
FNY Managed Accounts first reported a position in BioTelemetry, Inc. in Q3 2014 and held it in 5 quarters.
FNY Managed Accounts's BioTelemetry, Inc. position peaked at $222K in Q1 2015.
202 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2018.

Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.